125 related articles for article (PubMed ID: 21621603)
21. Biologic therapies and pregnancy: the story so far.
Hyrich KL; Verstappen SM
Rheumatology (Oxford); 2014 Aug; 53(8):1377-85. PubMed ID: 24352337
[TBL] [Abstract][Full Text] [Related]
22. Birth defects among infants born to women who received anthrax vaccine in pregnancy.
Ryan MA; Smith TC; Sevick CJ; Honner WK; Loach RA; Moore CA; Erickson JD
Am J Epidemiol; 2008 Aug; 168(4):434-42. PubMed ID: 18599489
[TBL] [Abstract][Full Text] [Related]
23. [Drugs news].
Bejan-Angoulvant T; Beau-Salinas F; Lengellé C; Cissoko H; Jonville-Béra AP
Arch Pediatr; 2014 Sep; 21(9):1051-2. PubMed ID: 25104577
[No Abstract] [Full Text] [Related]
24. Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31.
Steenholdt C; Al-Khalaf M; Ainsworth MA; Brynskov J
J Crohns Colitis; 2012 Apr; 6(3):358-61. PubMed ID: 22405174
[TBL] [Abstract][Full Text] [Related]
25. Infliximab use in children and adolescents with inflammatory bowel disease.
de Ridder L; Benninga MA; Taminiau JA; Hommes DW; van Deventer SJ
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):3-14. PubMed ID: 17592358
[TBL] [Abstract][Full Text] [Related]
26. Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children.
Liu Z; Julsgaard M; Zhu X; Martin J; Barclay ML; Cranswick N; Gibson PR; Gearry RB; van der Giessen J; Connor SJ; Rosella O; Grosen A; Toong C; Flanagan E; Wieringa JW; Janneke van der Woude C; Bell SJ;
J Crohns Colitis; 2022 Dec; 16(12):1835-1844. PubMed ID: 35779236
[TBL] [Abstract][Full Text] [Related]
27. Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy.
Kavanaugh A; St Clair EW; McCune WJ; Braakman T; Lipsky P
J Rheumatol; 2000 Apr; 27(4):841-50. PubMed ID: 10782805
[TBL] [Abstract][Full Text] [Related]
28. [Drug-induced alveolitis associated with infliximab/azathioprine therapy].
El-Hag K; Dercken HG; Prenzel R; Hölzle E
Pneumologie; 2008 Apr; 62(4):204-8. PubMed ID: 18270925
[TBL] [Abstract][Full Text] [Related]
29. An atypical presentation of visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with infliximab.
Kritikos K; Haritatos E; Tsigkos S; Gounari P; Skrapari I; Gounaris T; Sioula E
J Clin Rheumatol; 2010 Jan; 16(1):38-9. PubMed ID: 20051756
[TBL] [Abstract][Full Text] [Related]
30. Infliximab treatment of rheumatoid arthritis and Crohn's disease.
Nahar IK; Shojania K; Marra CA; Alamgir AH; Anis AH
Ann Pharmacother; 2003 Sep; 37(9):1256-65. PubMed ID: 12921510
[TBL] [Abstract][Full Text] [Related]
31. Developmental immunotoxicology assessment of rituximab in cynomolgus monkeys.
Vaidyanathan A; McKeever K; Anand B; Eppler S; Weinbauer GF; Beyer JC
Toxicol Sci; 2011 Jan; 119(1):116-25. PubMed ID: 20937725
[TBL] [Abstract][Full Text] [Related]
32. Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice.
Zabana Y; Domènech E; Mañosa M; Garcia-Planella E; Bernal I; Cabré E; Gassull MA
Aliment Pharmacol Ther; 2010 Mar; 31(5):553-60. PubMed ID: 20002026
[TBL] [Abstract][Full Text] [Related]
33. Anti-TNF-α therapy may cause neonatal neutropenia.
Guiddir T; Frémond ML; Triki TB; Candon S; Croisille L; Leblanc T; de Pontual L
Pediatrics; 2014 Oct; 134(4):e1189-93. PubMed ID: 25266439
[TBL] [Abstract][Full Text] [Related]
34. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study.
Fidder H; Schnitzler F; Ferrante M; Noman M; Katsanos K; Segaert S; Henckaerts L; Van Assche G; Vermeire S; Rutgeerts P
Gut; 2009 Apr; 58(4):501-8. PubMed ID: 18832524
[TBL] [Abstract][Full Text] [Related]
35. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
Chang S; Ball R; Braun MM
Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
[TBL] [Abstract][Full Text] [Related]
36. Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies.
Svenson M; Geborek P; Saxne T; Bendtzen K
Rheumatology (Oxford); 2007 Dec; 46(12):1828-34. PubMed ID: 18032541
[TBL] [Abstract][Full Text] [Related]
37. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.
Lee JH; Slifman NR; Gershon SK; Edwards ET; Schwieterman WD; Siegel JN; Wise RP; Brown SL; Udall JN; Braun MM
Arthritis Rheum; 2002 Oct; 46(10):2565-70. PubMed ID: 12384912
[TBL] [Abstract][Full Text] [Related]
38. Bedsharing and maternal smoking in a population-based survey of new mothers.
Lahr MB; Rosenberg KD; Lapidus JA
Pediatrics; 2005 Oct; 116(4):e530-42. PubMed ID: 16199682
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.
Colvin J; Bower C; Dickinson JE; Sokol J
Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678
[TBL] [Abstract][Full Text] [Related]
40. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.
Maser EA; Villela R; Silverberg MS; Greenberg GR
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1248-54. PubMed ID: 16931170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
